期刊文献+

纤溶酶原激活物抑制因子1基因多态性与过敏性紫癜胃肠道出血的相关性 被引量:8

Relationship between plasminogen activator inhibitor-1 gene polymorphism and gastrointestinal bleeding in Henoch-Schonlein purpura
下载PDF
导出
摘要 目的研究纤溶酶原激活物抑制因子1(PAI-1)基因启动子区单核苷酸多态位点(4G/5G)和血浆PAI-1水平与过敏性紫癜(HSP)胃肠道出血的相关性。方法入选HSP急性期患儿524例,按是否有消化道出血分为消化道出血组(出血组,186例)和非消化道出血组(对照组,338例),比较分析两组患儿PAI-1基因型、PAI-1血清水平以及其他和凝血纤维溶解相关的指标。结果出血组患儿的血小板计数(PLT)、血小板分布宽度(PDW)、血清D-二聚体(DD)、血清PAI-1水平均高于对照组,而平均血小板体积(MPV)和血浆纤维蛋白原(FIB)水平低于对照组,差异均有统计学意义(P?<?0.05);出血组患儿的4G/4G基因型频率较对照组高,差异有统计学意义(P=0.04)。4G/4G基因型的血浆PAI-1水平、DD水平高。结论 PAI-1 4G/5G基因多态性可能通过影响血浆PAI-1表达水平以及凝血纤溶等因素而影响过敏性紫癜消化道出血的病理过程。 Objective To investigate the relationship of single nucleotide polymorphism (4G/5G) in the promoter of plasminogen activator inhibitor-1 (PAI-1) and plasma PAI-1 level with gastrointestinal bleeding in Henoch-Sch?nlein purpura (HSP). Methods A total of 524 children with HSP in acute phase were recruited, and divided into gastrointestinal bleeding group (bleeding group, n?=?186) and non-gastrointestinal bleeding group (control group, n?=?338). The genotype frequency of 4G/5G polymorphism, the plasma PAI-1 level, and other parameters related to coagulation and ifbrinolysis were measured and compared between two groups. Results The levels of platelet count (PLT), platelet distribution width (PDW), serum D dimer (DD), serum PAI-1 were signiifcantly higher in the bleeding group than those in the control group, and the levels of mean platelet volume (MPV) and plasma ifbronectin protein of ifbrinogen (FIB) were signiifcantly lower in the bleeding group than those in the control group (P?<?0.05). The genotype frequency of 4G/4G was signiifcantly higher in the bleeding group than that in the control group (P?=?0.044). The plasma PAI-1 level and DD level was high in 4G/4G genotype. Conclusions The gene polymorphism of PAI-1 4G/5G may affect the pathological process of gastrointestinal bleeding in HSP by inlfuencing the expression of PAI-1 and other factors related to coagulation and ifbrinolysis systems.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第3期197-200,共4页 Journal of Clinical Pediatrics
基金 武汉市黄鹤英才(医疗卫生专项)计划专项经费资助(No.武人才办﹝2014﹞10号)
关键词 基因多态性 过敏性紫癜 消化道出血 儿童 polymorphism Henoch-Schonlein purpura gastrointestinal bleeding child
  • 相关文献

参考文献15

  • 1Pohl M. Henoch-Sch鰊lein purpura nephritis [J]. PediatrNephrol, 2015, 30(2): 245-252.
  • 2Iwaki T, Urano T, Umemura K. PAI-1, progress inunderstanding the clinical problem and its aetiology [J]. BrJ Haematol, 2012, 157(3): 291-298.
  • 3Eriksson P, Kallin B, van抰 Hooft FM, et al. Allele-specificincrease in basal transcription of the plasminogen-activatorinhibitor 1 gene is associated with myocardial infarction [J].Proc Natl Acad Sci USA, 1995, 92(6): 1851-1855.
  • 4Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PreS endorsedconsensus criteria for the classification of childhoodvasculitides [J]. Ann Rheum Dis, 2006, 65(7): 936-941.
  • 5Besbas N, Erbay A, Saat U, et al. Thrombomodulin, tissueplasminogen activator and plasminogen activator inhibitor-1in Henoch-Schlein purpura [J]. Clin Exp Rheumatol,1998, 16(1): 95-98.
  • 6Prandota J, Pankow-Prandota L, Kotecki L. Impaired activationof the fibrinolytic system in children with Henoch-Schleinpurpura: beneficial effect of hydrocortisone plus Sigmaaminocaproicacid therapy on disappearance rate of cutaneousvasculitis and fibrinolysis [J]. Am J Ther, 2001, 8(1): 11-19.
  • 7Brendel-Mler K, Hahn A, Schneppenheim R, et al.Laboratory signs of activated coagulation are commonin Henoch-Schlein purpura [J]. Pediatr Nephrol, 2001,16(12): 1084-1088.
  • 8Alioglu B, Ozsoy MH, Tapci E, et al. Successful use ofrecombinant factor VIIa in a child with Schnlein-Henochpurpura presenting with compartment syndrome and severefactor XIII deficiency [J]. Blood Coagul Fibrinolysis, 2013,24(1): 102-105.
  • 9Uluca - Ece A, V, et al. Management of intestinalbleeding with single-dose cyclophosphamide in Henoch-Schlein purpura [J]. Pediatr Int, 2015, 57(3): 498-500.
  • 10陈香美.凝血纤溶系统与细胞外基质调控系统在肾脏疾病中的作用[J].中华肾脏病杂志,2001,17(5):348-349. 被引量:61

二级参考文献41

  • 1李洪娟,王新良.过敏性紫癜凝血活性分子标志物研究进展[J].实用儿科临床杂志,2007,22(9):708-710. 被引量:8
  • 2Chang WL, Yang YH, Lin YT, et al.Gastro intestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients. Acta Pediatr,2004,93:1427-1431.
  • 3Evans-Jones LG, Clough JV.Thrombocytosis in Henoch-Schonlein syndrome. Clin Lab Haematol,1990,12:137-139.
  • 4Eldor A, Avitzour M, Or R, et al. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J, 1982,285:397-400.
  • 5Bitton A, Peppercorn MA. Emergencies in inflammatory bowel disease. Crit Care Clin,1995,11:513-529.
  • 6Reddy SB, Jeejeebhoy KN.Acute complications of Crohn's disease. Crit Care Med,1988,16:557-561.
  • 7Lin CY, Yang YH, Lee CC,et al. Thrombopoietin and interleukin- 6 levels in Henoch-Schnlein purpura. J Microbiol Immunol Infect,2006,39:476-482.
  • 8Fretzayas AP, Sionti I, Moustaki M, et al. Henoch- Schfinlein purpura: a long-term prospective study in Greek children [J]. J Clin Rheumatol,2008,14(6):324-331.
  • 9Roberts PF, Waller TA, Brinker TM, et al. Henoch- Schtinlein purpura: a review article [J]. South Med J,2007, 100(8) :821-824.
  • 10Prais D, Amir J, Nussinovitch M. Recurrent Henoch- Schtinlein purpura in children [J]. J Clin Rheumatol,2007, 13(1) :25-28.

共引文献88

同被引文献103

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部